Omnimmune Holdings, Inc.
OTC: OMMH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Saul Leal
- Employees
- 2
- Headquarters
- Houston, United States
- IPO year
- 2007
- Market cap
- $981.0
- Website
- https://onemeta.ai
Loading OMMH…
Loading profile data…Frequently asked questions about OMMH
What does Omnimmune Holdings, Inc. (OMMH) do?
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment...
Where does OMMH trade?
Omnimmune Holdings, Inc. (OMMH) trades on the Other OTC.
What sector is OMMH in?
Omnimmune Holdings, Inc. (OMMH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Omnimmune Holdings, Inc.?
Saul Leal is the chief executive officer of Omnimmune Holdings, Inc. (OMMH).
Where is Omnimmune Holdings, Inc. headquartered?
Omnimmune Holdings, Inc. is headquartered in United States.
Does OMMH pay a dividend?
Omnimmune Holdings, Inc. (OMMH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OMMH go public?
Omnimmune Holdings, Inc. (OMMH) completed its initial public offering in 2007.